Screening Latent Tuberculosis Infection and Observing Preventive Therapy in Kidney Transplantation
Primary Purpose
Kidney Transplantation
Status
Unknown status
Phase
Not Applicable
Locations
Taiwan
Study Type
Interventional
Intervention
Examination of latent tuberculosis
Sponsored by
About this trial
This is an interventional screening trial for Kidney Transplantation focused on measuring Renal, Latent, Tuberculosis
Eligibility Criteria
Inclusion Criteria:
- Age between 20-65 and match one of below
- Waiting renal transplant or status post renal transplant
- Receiving long term dialysis
Exclusion Criteria:
- Not agree to be enrolled
- Suspected active TB
- HIV patients
- Viral hepatitis
- Using immunosuppressants within 3 months before enrollment
- Receiving lymphokine therapy
- Hemoglobin < 8 g/dL
- Serum bilirubin > 2.5 mg/dL
- AST or ALT > 2 times of upper normal limit
- Lactation or pregnancy
Sites / Locations
- National Taiwan University HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Arm Type
No Intervention
Placebo Comparator
Other
Experimental
Arm Label
Waiting for renal transplant_no screening of LTBI
Not waiting for renal transplant
Status post renal transplant
Waiting for renal transplant_ screening of LTBI
Arm Description
patients with renal failure and are waiting for renal transplant We do routine examination but no LTBI check
Dialysis patients who are not waiting for renal transplant
patients who have received renal transplant
patients with renal failure and are waiting for renal transplant We do routine examination in addition to LTBI check
Outcomes
Primary Outcome Measures
percentage of active TB
Secondary Outcome Measures
Full Information
NCT ID
NCT02782416
First Posted
May 11, 2016
Last Updated
December 13, 2016
Sponsor
National Taiwan University Hospital
1. Study Identification
Unique Protocol Identification Number
NCT02782416
Brief Title
Screening Latent Tuberculosis Infection and Observing Preventive Therapy in Kidney Transplantation
Official Title
A Randomized Study for Screening Latent Tuberculosis Infection and Observing Preventive Therapy in Patients Preparing for Kidney Transplantation
Study Type
Interventional
2. Study Status
Record Verification Date
December 2016
Overall Recruitment Status
Unknown status
Study Start Date
January 2014 (undefined)
Primary Completion Date
December 2017 (Anticipated)
Study Completion Date
December 2017 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
National Taiwan University Hospital
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Study the prevalence of LTBI in patients who are waiting renal transplant and monitor the incidence of active TB
Detailed Description
Study the prevalence of LTBI in patients who are waiting renal transplant and monitor the incidence of active TB
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Kidney Transplantation
Keywords
Renal, Latent, Tuberculosis
7. Study Design
Primary Purpose
Screening
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
800 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Waiting for renal transplant_no screening of LTBI
Arm Type
No Intervention
Arm Description
patients with renal failure and are waiting for renal transplant We do routine examination but no LTBI check
Arm Title
Not waiting for renal transplant
Arm Type
Placebo Comparator
Arm Description
Dialysis patients who are not waiting for renal transplant
Arm Title
Status post renal transplant
Arm Type
Other
Arm Description
patients who have received renal transplant
Arm Title
Waiting for renal transplant_ screening of LTBI
Arm Type
Experimental
Arm Description
patients with renal failure and are waiting for renal transplant We do routine examination in addition to LTBI check
Intervention Type
Other
Intervention Name(s)
Examination of latent tuberculosis
Primary Outcome Measure Information:
Title
percentage of active TB
Time Frame
4 years
10. Eligibility
Sex
All
Minimum Age & Unit of Time
20 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Age between 20-65 and match one of below
Waiting renal transplant or status post renal transplant
Receiving long term dialysis
Exclusion Criteria:
Not agree to be enrolled
Suspected active TB
HIV patients
Viral hepatitis
Using immunosuppressants within 3 months before enrollment
Receiving lymphokine therapy
Hemoglobin < 8 g/dL
Serum bilirubin > 2.5 mg/dL
AST or ALT > 2 times of upper normal limit
Lactation or pregnancy
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Chin-Chung Shu, MD
Phone
+886972653087
Email
ccshu139@ntu.edu.tw
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Chin-Chung Shu, MD
Organizational Affiliation
National Taiwan University Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
National Taiwan University Hospital
City
Taipei
ZIP/Postal Code
100
Country
Taiwan
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Chin-Chung Shu, MD
Phone
+886972653087
Email
ccshu139@ntu.edu.tw
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Screening Latent Tuberculosis Infection and Observing Preventive Therapy in Kidney Transplantation
We'll reach out to this number within 24 hrs